IL37 and neoplasm: IL-23 is produced mainly by DCs and myeloid cells via toll-like receptor (TLR) through either exogenous or endogenous signals including damage-associated molecular patterns (DAMPs), pathogen-associated molecular patterns (PAMPs) or tumor-associated factors [173,174,175].